학술논문

Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study
Document Type
Article
Source
In ESMO Open October 2021 6(5)
Subject
Language
ISSN
2059-7029